Citations

Showing 10 of 108081 citations.

Heart rate and heart rate variability during diagnostic and interventional neuroendovascular procedures
Essibayi, Muhammed Amir , Toma, Aureliana , Mowrey, Wenzhu , Qin, Jiyue , Hamad, Mousa , Ryvlin, Jessica , Holland, Ryan, Fluss, Rose , Altschul, Dorothea , Altschul, David , Altschul, David J , Essibayi, Muhammed Amir , Lin, Li-Mei

Mayo Clinic

Interventional Neuroradiology | March 22, 2023 | Volume: 31 | Issue: 2 | Pages: 235-240

10.1177/15910199231162472 | PMID 36947484 Get It

Introduction Heart rate variability (HRV) reflects the activity of the autonomic nervous system (ANS) and can be used as a potential predictor of stress-related cardiovascular diseases. This study aimed to assess whether physical and mental strain during the performance of cerebral endovascular procedure influence time-domain HRV parameters in operating surgeon. Materials and Methods Heart rate (HR) and HRV metrics were measured using a HR sensor chest strap before, during, and after neuroendovascular interventions performed by a single neurosurgeon. Three consecutive data series were reported by recording time domain: before procedure, during and after performing endovascular procedures. HR and HRV parameters were recorded during diagnostic and interventional neuroendovascular procedures. HR and HRV measures were analyzed by procedure type and recording time domain. Results HRV measures of a single endovascular neurosurgeon were recorded during 50 procedures. The median intraprocedural HRV score was the lowest and the median HR was the highest (HRV: 52, HR: 89 bpm) compared to preprocedural (HRV: 59, HR: 70 bpm) and postprocedural cardiovascular measures (HRV: 53, HR: 79, bpm, p < 0.001). On univariate linear regression, a negative association of interventional procedures with lower intraprocedural (β = −0.905, p = 0.001) and postprocedural (β = −1.12, p < 0.001) HRV scores compared to the diagnostic procedures was noted. Conclusions HRV is a reliable tool to measure cardiovascular and mental stress. Interventional neuro-endovascular procedures seem to negatively impact the cardiovascular measures of neurointerventionalists. Further longitudinal studies utilizing HRV are warranted to address their long-term effects on the mental health of physicians.
Proton therapy for high‐risk prostate cancer: Results from the Proton Collaborative Group PCG 001‐09 prospective registry trial
Lazarev, Stanislav , Garg, Madhur , Gozland, Rachel, Chang, John Wen‐Cheng , Hartsell, William F. , Chen, Jonathan , Vargas, Carlos , Gorovets, Daniel , Gozland, Rachel , Hasan, Shaakir , Tsai, Henry K. , Simone, Charles B.

Mayo Clinic

The Prostate | March 22, 2023 | Volume: 83 | Issue: 9 | Pages: 850-856

10.1002/pros.24525 | PMID 36946610 Get It

AbstractBackgroundData for proton therapy in high‐risk prostate cancer (HRPC) are limited. Using the Proton Collaborative Group prospective registry, we evaluated outcomes for HRPC patients treated with proton therapy.MethodsA totsl of 605 men with localized HRPC treated with proton therapy from 8/2009 to 3/2019 at nine institutions were selected. Outcomes examined included freedom from progression (FFP), metastasis free survival (MFS), overall survival (OS), and toxicity. Multivariable cox/binomial regression models were used to assess predictors of FFP and toxicity.ResultsMedian age was 71 years. Gleason grade groups 4 (49.4%) and 5 (31.7%) were most common, as were clinical stage T1c (46.1%) and cT2 (41.3%). The median pretreatment prostate specific antigen (PSA) was 9.18 and median International Prostate Symptom Score (IPSS) was 6. Androgen deprivation therapy was given in 63.6%. Median dose was 79.2 GyE in 44 fractions. Pelvic lymph nodes were treated in 58.2% of cases. Pencil beam scanning was used in 54.5%, uniform scanning in 38.8%, and a rectal spacer in 14.2%. At a median followup of 22 months, the 3‐ and 5‐year FFP were 90.7% and 81.4%, respectively. Five‐year MFS and OS were 92.8% and 95.9%, respectively. Independent correlates of FFP included Gleason ≥8, PSA > 10, and cT2 (all p < 0.05). No grade 4 or 5 adverse events were reported. There were 23 (5%) grade 2 and 0 grade 3 gastrointestinal events. Prevalence of late grade 3, late grade 2, acute grade 3, and acute grade 2 genitourinary toxicity was 1.7%, 5.8%, 0%, and 21.8%, respectively. Prevalence of grade 2 and 3 erectile dysfunction at 2 years was 48.4% and 8.4%, respectively.ConclusionsIn the largest series published to date, our results suggest early outcomes using proton therapy for HRPC are encouraging for both safety and efficacy. Further evaluation is needed to determine if an advantage exists to use protons over other radiation techniques in this population.
Tyrosine phosphorylation of YAP‐1 in biliary epithelial cells mediates posthepatectomy liver regeneration and is affected by serotonin
Starlinger, Patrick , Brunnthaler, Laura, Watkins, Ryan , Stift, Judith , Santol, Jonas , Assinger, Alice , Smoot, Rory L. , Smoot, Rory L , Assinger, Alice , Starlinger, Patrick , Santol, Jonas , Pereyra, David , Finsterbusch, Michaela , Gruenberger, Thomas

Mayo Clinic

Journal of Cellular Biochemistry | March 22, 2023 | Volume: 124 | Issue: 5 | Pages: 687-700

10.1002/jcb.30398 | PMID 36946436 Get It

AbstractExperimental data suggested activation of yes‐associated protein (YAP‐1) as a critical regulator of liver regeneration (LR). Serotonin (5‐HT) promotes LR in rodent models and has been proposed to act via YAP‐1. How 5‐HT affects LR is incompletely understood. A possible mechanism how 5‐HT affects human LR was explored. Sixty‐one patients were included. Tissue samples prior and 2 h after induction of LR were collected. Circulating levels of 5‐HT and osteopontin (OPN) were assessed. YAP‐1, its phosphorylation states, cytokeratin 19 (CK‐19) and OPN were assessed using immunofluorescence. A mouse model of biliary epithelial cells (BECs) specific deletion of YAP/TAZ was developed. YAP‐1 increased as early as 2 h after induction of LR (p = 0.025) predominantly in BECs. BEC specific deletion of YAP/TAZ reduced LR after 70% partial hepatectomy in mice (Ki67%, p < 0.001). SSRI treatment, depleting intra‐platelet 5‐HT, abolished YAP‐1 and OPN induction upon LR. Portal vein 5‐HT levels correlated with intrahepatic YAP‐1 expression upon LR (R = 0.703, p = 0.035). OPN colocalized with YAP‐1 in BECs and its circulating levels increased in the liver vein 2 h after induction of LR (p = 0.017). In the context of LR tyrosine‐phosphorylated YAP‐1 significantly increased (p = 0.042). Stimulating BECs with 5‐HT resulted in increased YAP‐1 activation via tyrosine‐phosphorylation and subsequently increased OPN expression. BECs YAP‐1 appears to be critical for LR in mice and humans. Our evidence suggests that 5‐HT, at least in part, exerts its pro‐regenerative effects via YAP‐1 tyrosine‐phosphorylation in BECs and subsequent OPN‐dependent paracrine immunomodulation.
Author response: O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors
Zhang, Zengdi , Awad, Mohamed E. , Elsalanty, Mohammed , Maynard, Jason C. , Burlingame, Alma L. , Huang, Zan , Cray, James , Ball, Lauren Elizabeth , Zeng, Hu , Mansky, Kim C. , Ruan, Hai‐Bin

Mayo Clinic

No container title available | March 22, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.85464.sa2 Get It

Rupture of an Aortic Aneurysm into the Pulmonary Artery
Heath, Donald, Parker, Robert L., Edwards, Jesse E., Parker, Robert L.

Mayo Clinic

International Journal of Clinical Practice | March 22, 2023 | Volume: 12 | Issue: 10 | Pages: 701-706

10.1111/j.1742-1241.1958.tb03036.x Get It

Primary Pancreatic Undifferentiated Pleomorphic Sarcoma
Patel, M. , Agrawal, Upasana, Kendziora, Ryan W., Vege, Santhi Swaroop , Sweetser, Seth , Patel, Mehrie Harshad , Guerrero Vinsard, Daniela , Swaroop Vege, Santhi, Vinsard, Daniela Guerrero , Siontis, Brittany L.

Mayo Clinic

ACG Case Reports Journal | March 22, 2023 | Volume: 10 | Issue: 3 | Pages: e01011

10.14309/crj.0000000000001011 | PMID 36968124 Get It

ABSTRACT Primary pancreatic sarcomas are rare malignancies with an incidence of 0.1%. This case report is of a 48-year-old man who presented with this condition. The patient's treatment plan consisted of distal pancreatectomy and splenectomy with intraoperative immunohistochemistry and adjuvant chemotherapy. To correctly identify and treat undifferentiated pleomorphic sarcoma, a stepwise strategy involving cross-sectional imaging and extensive histopathology analysis is necessary.
Multiplex Detection of Infectious Diseases on Microfluidic Platforms
Chen, Fumin , Hu, Qinqin , Li, Huimin , Xie, Yi , Xiu, Leshan , Zhang, Yuqian , Guo, Xiaokui , Yin, Kun

Mayo Clinic

Biosensors | March 22, 2023 | Volume: 13 | Issue: 3 | Pages: 410

10.3390/bios13030410 | PMID 36979622 Get It

Infectious diseases contribute significantly to the global disease burden. Sensitive and accurate screening methods are some of the most effective means of identifying sources of infection and controlling infectivity. Conventional detecting strategies such as quantitative polymerase chain reaction (qPCR), DNA sequencing, and mass spectrometry typically require bulky equipment and well-trained personnel. Therefore, mass screening of a large population using conventional strategies during pandemic periods often requires additional manpower, resources, and time, which cannot be guaranteed in resource-limited settings. Recently, emerging microfluidic technologies have shown the potential to replace conventional methods in performing point-of-care detection because they are automated, miniaturized, and integrated. By exploiting the spatial separation of detection sites, microfluidic platforms can enable the multiplex detection of infectious diseases to reduce the possibility of misdiagnosis and incomplete diagnosis of infectious diseases with similar symptoms. This review presents the recent advances in microfluidic platforms used for multiplex detection of infectious diseases, including microfluidic immunosensors and microfluidic nucleic acid sensors. As representative microfluidic platforms, lateral flow immunoassay (LFIA) platforms, polymer-based chips, paper-based devices, and droplet-based devices will be discussed in detail. In addition, the current challenges, commercialization, and prospects are proposed to promote the application of microfluidic platforms in infectious disease detection.
Quantitative Biomarkers Derived from a Novel Contrast-Free Ultrasound High-Definition Microvessel Imaging for Distinguishing Thyroid Nodules
Kurti, Melisa, Sabeti, Soroosh , Robinson, Kathryn A. , Scalise, Lorenzo , Larson, Nicholas B. , Fatemi, Mostafa , Alizad, Azra , Fatemi, Mostafa , Larson, Nicholas B , Alizad, Azra

Mayo Clinic

Cancers | March 22, 2023 | Volume: 15 | Issue: 6 | Pages: 1888

10.3390/cancers15061888 | PMID 36980774 Get It

Low specificity in current ultrasound modalities for thyroid cancer detection necessitates the development of new imaging modalities for optimal characterization of thyroid nodules. Herein, the quantitative biomarkers of a new high-definition microvessel imaging (HDMI) were evaluated for discrimination of benign from malignant thyroid nodules. Without the help of contrast agents, this new ultrasound-based quantitative technique utilizes processing methods including clutter filtering, denoising, vessel enhancement filtering, morphological filtering, and vessel segmentation to resolve tumor microvessels at size scales of a few hundred microns and enables the extraction of vessel morphological features as new tumor biomarkers. We evaluated quantitative HDMI on 92 patients with 92 thyroid nodules identified in ultrasound. A total of 12 biomarkers derived from vessel morphological parameters were associated with pathology results. Using the Wilcoxon rank-sum test, six of the twelve biomarkers were significantly different in distribution between the malignant and benign nodules (all p < 0.01). A support vector machine (SVM)-based classification model was trained on these six biomarkers, and the receiver operating characteristic curve (ROC) showed an area under the curve (AUC) of 0.9005 (95% CI: [0.8279,0.9732]) with sensitivity, specificity, and accuracy of 0.7778, 0.9474, and 0.8929, respectively. When additional clinical data, namely TI-RADS, age, and nodule size were added to the features, model performance reached an AUC of 0.9044 (95% CI: [0.8331,0.9757]) with sensitivity, specificity, and accuracy of 0.8750, 0.8235, and 0.8400, respectively. Our findings suggest that tumor vessel morphological features may improve the characterization of thyroid nodules.
Elementary Overview of Heavy Metals
Jannetto, Paul J. , Cowl, Clayton T.

Mayo Clinic

Clinical Chemistry | March 22, 2023 | Volume: 69 | Issue: 4 | Pages: 336-349

10.1093/clinchem/hvad022 | PMID 36945128 Get It

AbstractBackgroundExposure to heavy metals is common as a result of environmental contamination of air, water, and soil as well as accumulation in food, tobacco, herbal medicines, and occupational contact. However, clinically relevant toxicity is much less prevalent. Toxic effects, when they occur, may present with non-specific symptoms, resulting in a very large differential for clinicians to consider.ContentArsenic, cadmium, lead, and mercury are four heavy metals with no biological role in humans. However, these metals are commonly used in industrial applications and consumer products. Since these elements are not biodegradeable, their potential toxic effects may be long-lasting within the environment. These heavy metals have the potential to accumulate in vital organs such as the brain, heart, and kidney where they may disrupt normal cellular functioning and if exposures are repetitive or of high concentration, toxicity may result.SummaryThe objective of this review is to provide an overview of arsenic, cadmium, lead, and mercury physical properties, common sources of exposure, basic toxicokinetics and health effects, and to review clinical guidelines and treatment strategies. Acute and chronic symptoms and recommended laboratory biomarker testing are also discussed.
Apelin is altered in subjects with autosomal dominant polycystic kidney disease and preserved kidney function
Cools, Wilfried , Decuypere, Jean-Paul , Vennekens, Rudi , Llorens‐Cortés, Catherine , Janssens, Peter , Mota, Nadia De , Torres, Vicente E. , Wissing, Karl Martin , Bammens, Bert , Mekahli, Djalila

Mayo Clinic

Nephrology Dialysis Transplantation | March 22, 2023 | Volume: 38 | Issue: 8 | Pages: 1907-1911

10.1093/ndt/gfad056 | PMID 36945109 Get It